The study was to determine the appropriate dose and administration route of Ornitin Triple vaccine in cross-breed coloured broilers in Vietnam by evaluating the antibody titer against Ornithobacterium rhinotracheale (ORT) and local reactions at injection sites on chickens after vaccination. The study was divided into 2 trials. Both trials were designed with 3 vaccine dose groups: 0.0ml (control group), 0.25ml and 0.5ml and 2 different administration routes: subcutaneous at neck (SC) and intramuscular at breast (IM) injection. The result showed that, no statistically significant difference was found between antibody titer of two administration routes as well as 2 vaccine doses until 13-week-old. Local reactions at the injection sites of IM route was less severe than SC at neck and in higher dose would produce a more severe swelling reaction. Daily weight gain was found to have a slight decrease in the vaccinated groups within 2 weeks after vaccination, however, no statistically significant difference was found in later stage (P > 0.05). In conclusion, Ornitin Triple can be used to vaccinate by IM with the dose of 0.25ml for coloured broilers at early age (3-week-old), or 0.5ml for older birds and should be careful for some reactions at the injection sites.
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ORT disease swelling reaction titer IDEXX bacteria vaccine 1. Introduction R espiratory diseases are the most common among the considerably difficult problems and account for a high proportion in poultry diseases. There are many different causes for respiratory diseases including microorganism factors and farms' management [8] . Among those, bacteria Ornithobacterium rhinotracheale (ORT) plays an important part in causing complex respiratory syndromes with high mortality [15] . Diversity of ORT with 18 serotypes (type A to type R), serotype A was the most common with 94% [4, 7] . Beside that, a survey on random samples, Numee et al found that 3 common serotypes were A (35.5%), B (19.4%), and C (12.9%) [11] . Unlike other repiratory causes, ORT was discovered rather late; it was not known until 1981; the first case of ORT infection was found in turkeys in Germany [3] . Mortality rate of ORT was from 1% to 15% in chickens aged 2-8 weeks old; however, in cases where ORT was followed by a sencondary infection, mortality rate could reach up to 50% [5] . Common clinical signs caused by ORT include coughing, nasal discharge, labored breathing, decreased feed and water intake and could lead to death [9] . In breeders, the disease could cause the flock to decrease its egg production as well as produce weak offsprings [5] . As ORT is a slow grower and require a really special growing environment, other bacteria (such as E.coli), which have the ability to grow fast and easily, would be dominant in the infected organs [12] . Moreover, ORT is usually a secondary infection to other diseases such as Infections bursal disease (IBD), Newcastle (ND) and Infectious Bronchitis (IB). These are all factors contributing to the late or misdiagnosis and hinder prevention of ORT infection and therefore would leave a negative impact on the economy. In 1998, according to John R. Glisson, treatment with antibiotics was more efficient than using vaccine [8] . However, one year later, Van Empel and Hafez (1999) found that treatment of ORT with antibiotics would be extremely difficult due to the fact that most ORT strains had already developed antibiotic resistance [16] . In 2001, Devries et al found that ORT bacteria strains were already resistant to 80-100% of commonly used antibiotics in treating poultry, namely ampicillin, ceftiofur, tylosin, spiramycin, lincomycin, tilmicosin, flumequine, enrofloxacin and doxycycline [6] . As a result, deeper research into ways to prevent the disease might be a more effective solution against ORT. Van Empel et al. (1999) carried on a study on the ORT vaccine with an oil adjuvant capable of reducing clinical signs of the disease. From that, this study carried on to evaluate the serum HGA and the reaction at the injection site of the chicken after vaccination [16] . In 2002, Cauwerts et al conducted an experiment on vaccine against ORT in Belgium and brought about good results such as a decrease in mortality rate and an increase in poultry production performance [2] . In 2005, Schuijffel et al proved the ability to generate cross protection against different serotypes of ORT [14] . However, bacterial vaccines are often seen causing strong reactions in poultry as well as the level of immune response largely depends on the reaction at the injection sites and vaccine antigen [13] . As a result, this research was the first in Vietnam to determine the appropriate doses, administration routes and age in order to simultaneouly minimize the side effects and be able to produce a high and prolonged antibody titer to protect local cross-breed broilers from ORT.
Materials and Methods

Materials
Ornitin Triple (Phibro Animal Health, USA) is an oil emulsion vaccine. In the dose of 0.5ml, the antigen amount consists of 10 9 CFU for each serotype A, B and C. Vaccine is recommended to use in prevention of respiratory diseases caused by ORT. Information of vaccine bottle was used in this study: the batch number: 24461034 and expiry date: 23-05-2020.
Cross-breed colored broilers chickens in Vietnam or namedly backyard chickens or native chickens are raised for 14-16 weeks, with live body weigh at slaughter time in average for 2 -2.5 kg/bird.
Methods
Experimental Design
The research consisted of 2 trials:
Trial I: 108 3-week-old local cross-bred broilers Trial II: 120 5-week-old local cross-bred broilers All chickens in both trials were tagged individually on the legs. They were initially weighed, measured for ORT antibody before vaccinated and randomly allocated into six groups according to 2 factors shown in Table 1 .
(1) 0.0ml represented control group, injected with 0.5ml saline solution (NaCl 0.9%).
(2) 0.25ml represented test group injected with 0.25ml Ornitin Triple vaccine.
(3) 0.5ml represented test group injected with 0.5ml 
Effects of Administration Routes, Doses and Age to ORT Antibody Titer
In each experiment, a total of 18-20 chickens were numbered and 10 were randomly selected for serum sample. Those 10 chickens were recorded of their tag number for later reference. Until they reached the age of 13 weeks old, in both experiments, 5 serum samples were collected in each cage. There were 30 serum samples in each trial collected each collecting time. A total of 600 serum samples from both trials were taken during the study.
ORT antibody titer in chickens' serum samples was tested using ELISA technique by IDEXX commercial kit, IDEXX ORT Ab Test, USA, product code 99-43600. According to the recommendation of the manufacturer, grouping of ORT antibody titer was shown in Table 2 and samples with titer ≤ 844 would be considered as negative, and samples with titer ≥ 844 would be considered as positive (IDEXX, USA).
Evaluation of the Safety of Ornitin Triple vaccine
The safety of the vaccine was evaluated by chickens' general body reactions and local reactions at the injection sites after vaccination. Chickens' general body reactions of each group were assessed by body temperature and feed intake. Body temperature of chickens was measured using Amrus thermometer from 4PM to 6PM on day 1, 2, 4, 5, 6, 8, 10, 14 after vaccination. Each group's feed intake was also recorded for 14 continuous days after vaccination. Chickens' local reactions at the injection sites were observed and scored: no swelling = 0 point, swelling less than 1cm = 1 point, swelling from 1-2 cm = 2 points, and swelling more than 2 cm = 3 points.
Evaluation of Vaccine's Effects to Chickens' Performance
Chickens were weighed and recorded individually; their daily average weight gain (DAWG) was calculated using the following formula:
DAWG =
Weight after Weight before Age after Age before
Experimental Data Analysis
Data was collected and managed by MS Excel 2010 (Microsoft, USA). Analyzed by T-student test for 2 group of trials, and by ANOVA variance analysis method of software R version 6.3.1.
Results and Discussions
Evaluation of the Level of ORT Antibody Titer before and after Vaccination
Before vaccination, ORT antibody titer of chickens from all groups were recorded as negative (titer ≤ 844). According to IDEXX, chickens that were not vaccinated against ORT and not infected with ORT by field strains would be considered as negative against ORT and therefore, be classified into group 0 (Figure 1, Figure 2 ) ( Table 2 ).
The results of chickens' ORT antibody titer 3 weeks after vaccination were displayed in Figure 1 and 2. There was a significant difference between vaccinated groups and the control group in terms of ORT antibody titer. In trial I, 3 weeks after vaccination (chickens reached the age of 6 weeks), their ORT antibody titers would be classified into group 8 and above, with the average titer belonging to group 13 or 14, equivalent to 19000 -20000 titer unit. In trial II, 3 weeks after vaccination (chickens reached the age of 8 weeks), the lowest ORT antibody titer was recorded at group 15 range with the average titer falling into group 16 or 17. In figure 1, titers ranged from group 8 to 16 while in figure 2, titers ranged from group 15 to 18. This result showed that older chickens can produce higher and more uniform ORT antibody titers 3 weeks after vaccination. 
ORT Antibody Titer Post Vaccination
Each group's ORT antibody titers at different ages from trial I and II were recorded in Table 3 and 4, respectively. Before vaccination, ORT antibody titers of all groups were similarly low and not significanly difference (P > 0.05). After vaccination, both trials' vaccinated groups experienced an increase in antibody titer compared to the control groups (P < 0.001). In addition, 2 weeks after vac-cination, both trial I and trial II had ORT antibody titers surged significantly, while in control groups, all were in negative group (Table 3 , Table 4 ).
Effects of Administration Routes to ORT Antibody Titer
According to Bermudez (2008) , vaccines needed to be administered at the correct sites in order to achieve the best immune response for poultry [1] . Different type of vaccine would require a different optimal injection site. The effects of administration routes were evaluated based on assessing groups with the same administration dose of each trial. In trial I, with the vaccine dose of 0.25 ml, ORT antibody titer of SC route was not different from that of IM route; similarly, there was no statistical significance between 2 administration routes with the vaccine dose of 0.5 ml (P > 0.05) (table 3) . The same situation applied to trial II when assessing 2 administration routes with no difference found (P > 0.05) (table 4) . It can be concluded that, SC or IM injection does not affect the ORT antibody titer of coloured broilers, as there was no significant difference found between the 2 injection routes. Although, there was no statistically difference between SC and IM, it should be carefully to use IM at breast route for broilers to be slaughtered less than 6 weeks after vaccination because IM injection will damage inside the muscle and leave consequences on the carcass quality.
Effects of Vaccine Doses to ORT Antibody Titer
The effect of injection dose on the antibody titer was as- sessed similarly to that of the injection routes. In trial I (Table 3), there was no difference between the injection dose of 0.25 and 0.5 ml of the same SC or IM injection route (P> 0.05). Trial II provided similar results to trial I (Table 4) . It was clear from comparing results of both trials that the antibody titer of experimental chicken groups was not dependant on the injection doses up to 13 weeks old ( Table 3 , Table 4 ). This results were obtained only until 13 weeks, it is possible that there is simply not sufficient time to reflect a long of immunity response to higher injection doses (0.5ml vs 0.25ml). Therefore, for chickens raising in longer than 13 weeks, 0.5ml dose should be considered.
Effects of Vaccination Age to ORT Antibody Titer
The comparison of ORT antibody titer after vaccination between trial I and trial II was conducted by T test and the results were shown in Table 5 . These 2 trials was conducted on chickens of 2 different age groups (Table 5) , trial I used 3-week-old chickens and trial II used 5-week-old chickens. According to the results of comparing ORT antibody titers of these 2 trials, it was found that the antibody titer after vaccination with the vaccine dose of 0.25 ml in trial I was lower than that of trial II at the times of 2, 3 and 7 weeks after vaccination (P < 0.05).
Likewise, at week 2 and 3 after vaccination with the vaccine dose of 0.5 ml, the ORT antibody titer of trial I was also lower than trial II (P < 0.001). However, after that and when the chickens reached the age of 13 weeks, no statistical difference was found between the trials (P > 0.05). As a result, it could be concluded that with the same vaccine doses, ORT antibody titer of 3-week-old chickes would increase at a slower rate compared to 5-week-old chickens; however, there would be no difference found between chickens of older age groups. As recommended by vaccine manufacturer Ornitin Triple, the vaccine is suitable for turkeys 6 weeks of age and the appropriate vaccine dose is 0.5ml. However, there have been no specific recommendations for the local chicken breeds in Vietnam, which are raised for 13-16 weeks (turkeys are 20 weeks or more) and were especially susceptible to ORT at 5-6 weeks of age (Vo et al, 2019) .
The appropriate age for vaccination of chickens was in accordance with the body weight, the level of completion of the immune system, health status, disease pressures and especially the effects of bacterial vaccines which often caused a strong reaction in vaccinated chickens (Nguyen Ba Hien et al, 2007) . Figure 3 showed that if chickens can wait until 5-week-old to be vaccinated would be better than 3-week-old chickens. However, if ORT outbreak happen about 5-6 weeks of age then chickens should be vaccinated at least 2 weeks before that, which is 3-week-old. Figure 3 also showed that for chickens raised less than 13 weeks, 0.25ml dose would be good enough, however, for chickens raised more than 13 weeks, 0.5ml dose should be considered.
Vaccine Reaction
General Body Reactions of Chickens
Body temperature
There was a fluctuation in body temperature after vaccination from day 5 of trial I and day 8 of trial II. There was a statistically significant difference between the control and vaccinated groups (P < 0.05). According to Nguyen Ba Hien et al, 2007, after vaccination, body temperature can increase by 0.5-1°C due to the immune responses that occur in the body. In this study, vaccination for younger chickens (3-week-old) would give a change in body temperature following the Ornitin Triple vaccination earlier (day 5 vs 8) than vaccination for older chickens (5-week-old) ( Table 6, Table 7 ). 
Feed intake
The effects of the vaccination to chickens' feed intake were evaluated in the same rearing environment in order to produce the most accurate result. The feed intake (g/ chicken/day) after vaccination of each group was recorded every 2-3 days. The results showed that the feed intake of chickens in both trials decreased after vaccination. However, around 3-4 weeks afterwards, no significant difference was found (table 8 and 9). 
Local Reactions at the Injection Sites
In the control groups, no reaction at the injection sites was recorded. In the vaccinated groups, swelling reaction started to increase 4-7 days after vaccination and peaked at 9-10 days after vaccination. In both trials, swelling reaction was found to develop the strongest in vaccinated groups with the dose of 0.5 ml by SC at neck and then 0.25 ml by SC at neck (Figure 4, Figure 5 ). In general, in both trials, IM route would produce a less severe swelling reaction compared to SC route; and at some time, the swelling at the injection sites of chickens with the vaccine dose of 0.5 ml would be more severe than those with the dose of 0.25 ml. 
Growth Performance
The performance of chickens in each group was evaluated by their daily weight gain and the results were shown in Table 8 and 9. In both trials, within 2 weeks after vaccination, the chickens' performance had been influenced by the vaccine (P < 0.001), especially the SC-0.5ml group was most seriously affected. However later on (up to 91 days old), no difference was found between vaccinated groups and control groups (P > 0.05).
A comparison between groups with the same administration routes or the same vaccine doses was performed in order to compare the effects of administration routes or vaccine doses to the perfomance of chickens.
In both trials, at the beginning of the first 2 weeks after vaccination, all vacination groups had a significant weight gain lower than the control groups ( Table 10 , Table 11 ). At the same time, the first 2 weeks of both experiments, SC groups with the vaccine dose of 0.5 ml was documented to have a significant lower weight gain than those with the IM group with the vaccine dose of 0.25 ml (P < 0.001) ( Table  10 , Table 11 ). This could be the result of swelling reaction which was found to develop the strongest in vaccinated groups with the dose of 0.5 ml by SC at neck (Figure 4 , Figure 5 ). The swelling reaction in the neck reduced feed intake especially during the first 2 weeks ( Table 8 , Table 9 ). Although, the vaccination groups did have an influence on chickens' performance at the beginning of both trials, however after two weeks, all vaccination groups recovered and no statistically significant influence on growth performance was documented (P> 0.05) ( Table 10 , Table 11 ).
Conclusion
In both trials, there was a development of ORT antibody titer by the 2 administration routes as well as with the 2 vaccine doses. The increase in antibody titer was quite stable in the vaccinated groups, which was statistically There was no antibody titer statistically difference found between the two administration routes with the same dose and age (P> 0.05). ORT antibody titer of vaccine doses were different at the beginning but no difference when chickens reached the age of 13 weeks. Chickens vaccinated at 3 weeks old had a slower immune response than 5-week-old chickens.
Reactions at the injection site began to fluctuate 5-8 days after vaccination. The swelling reaction at the injection site by IM was less severe than SC route. Simultaneously, the smaller the vaccine dose, the less severe the swelling reaction.
Chicken growth index was affected 2-3 weeks after vaccination, however, no difference was found in later stages compared to the control group, which was reflected by feed intake and weight gain.
In conclusion, it was recommended that Ornitin Triple vaccine could be used for the young cross-breed coloured broilers in Vietnam at the dose of 0.25ml by IM or 0.5ml for older broilers which need to raise for more than 13 weeks. Moreover, it was also necessary to pay attention to the reaction at the injection sites after vaccination.
